Celltrion Reports Positive Rheumatoid Arthritis Data From Subcutaneous Infliximab

 
• By Akriti Seth
  
Hands_Arthritis
Celltrion’s subcutaneous formulation of infliximab is comparable to the intravenous version in rheumatoid arthritis • Source: Shutterstock

More from Biosimilars

More from Products